Lipocine Inc.
LPCN
$1.98
-$0.07-3.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -89.58% | 899.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -89.58% | 899.48% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -89.58% | 899.48% | |||
| SG&A Expenses | 22.48% | 28.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.40% | 5.34% | |||
| Operating Income | -53.01% | 25.15% | |||
| Income Before Tax | -54.93% | 25.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -54.93% | 25.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -54.93% | 25.63% | |||
| EBIT | -53.01% | 25.15% | |||
| EBITDA | -53.34% | 25.28% | |||
| EPS Basic | -29.53% | 29.13% | |||
| Normalized Basic EPS | -29.54% | 29.16% | |||
| EPS Diluted | -29.22% | 29.12% | |||
| Normalized Diluted EPS | -29.54% | 29.16% | |||
| Average Basic Shares Outstanding | 19.61% | 4.95% | |||
| Average Diluted Shares Outstanding | 19.61% | 4.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||